Linden Thomas Advisory Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Buy
12,539
+329
+3% +$64.6K 0.21% 141
2026
Q1
$2.39M Buy
12,210
+257
+2% +$49.9K 0.23% 143
2025
Q4
$2.07M Buy
11,953
+257
+2% +$46.8K 0.21% 141
2025
Q3
$2.23M Buy
11,696
+94
+0.8% +$16.7K 0.23% 135
2025
Q2
$2.08M Buy
11,602
+89
+0.8% +$15.5K 0.23% 135
2025
Q1
$1.95M Buy
11,513
+63
+0.6% +$10.3K 0.25% 137
2024
Q4
$1.73M Sell
11,450
-1
-0% -$156 0.22% 161
2024
Q3
$1.78M Buy
11,451
+80
+0.7% +$11.9K 0.24% 150
2024
Q2
$1.56M Sell
11,371
-20
-0.2% -$2.74K 0.24% 159
2024
Q1
$1.52M Buy
11,391
+642
+6% +$83.3K 0.24% 162
2023
Q4
$1.48M Buy
10,749
+981
+10% +$129K 0.28% 150
2023
Q3
$1.19M Sell
9,768
-846
-8% -$113K 0.27% 174
2023
Q2
$1.49M Buy
10,614
+422
+4% +$58.2K 0.33% 103
2023
Q1
$1.44M Buy
10,192
+978
+11% +$140K 0.36% 104
2022
Q4
$1.44M Buy
+9,214
New +$1.32M 0.41% 85

Other funds holding DGX

Linden Thomas Advisory Services's DGX Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Quest Diagnostics (DGX) stake by 2.7% in Q2 2026, buying an estimated $64.6K and bringing the position to 12,539 shares worth $2.66M. The position accounts for 0.21% of the portfolio, ranked #141.

Linden Thomas Advisory Services first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Linden Thomas Advisory Services held 12,539 shares of Quest Diagnostics worth $2.66M as of Q2 2026.
  • Linden Thomas Advisory Services bought 329 Quest Diagnostics shares in Q2 2026, an estimated $64.6K.
  • Quest Diagnostics made up 0.21% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #141 holding.
  • Linden Thomas Advisory Services first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.